CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment
Jung Hyun Lee, Sung Gu Kang, Seung Tae Kim, Seok Ho Kang, In Keun Choi, Young Je Park, Sang Chul Oh, Deuk Jae Sung, Jae Hong Seo, Jun Cheon, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim, Kyong Hwa Park
Cancer Research and Treatment. 2014;46(2):172-177.   Published online 2014 April 15    DOI:

Excel Download

Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment
Cancer Research and Treatment. 2014;46(2):172-177   Crossref logo
Link1 Link2

Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve
Bulletin du Cancer. 2020;107(5):eS1-eS7   Crossref logo
Link1 Link2

Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma
International Journal of Urology. 2007;14(11):1000-1004   Crossref logo
Link1 Link2

P113 Design of an exploratory phase I study of pemetrexed in addition to vinflunine as second-line treatment in patients with metastatic urothelial cell carcinoma after prior treatment with platinum
European Urology Supplements. 2014;13(5):152-153   Crossref logo
Link1 Link2

Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)
BMC Cancer. 2015;15(1):   Crossref logo
Link1 Link2 Link3

Triplet chemotherapy with paclitaxel, gemcitabine, and cisplatin as second-line therapy for advanced urothelial carcinoma
Modern Chemotherapy. 2013;02(01):1-7   Crossref logo
Link1 Link2 Link3 Link4

Phase II Trial of 5-Fluorouracil/Leucovorin/Gemcitabine/Cisplatin as Second-Line Treatment in Patients with Metastatic or Recurrent Colorectal Carcinoma: A Cancer Therapeutics Research Group Study
Clinical Colorectal Cancer. 2007;6(9):646-651   Crossref logo
Link1 Link2

Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma
Cancer. 2006;106(11):2363-2368   Crossref logo
Link1 Link2

Impact of paclitaxel, cisplatin, and gemcitabine as first-line chemotherapy in cisplatin-fit and -unfit patients with advanced/metastatic urothelial carcinoma
Urologic Oncology: Seminars and Original Investigations. 2021;   Crossref logo
Link1 Link2

Re: Second-Line Chemotherapy in Older Patients with Metastatic Urothelial Carcinoma: Pooled Analysis of 10 Second-Line Studies
Journal of Urology. 2018;199(3):591-592   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.